Quidel | Les Charges D'Exploitation



Operating Expenses Changement Date
Abbott USD 9.06B 298M 2024-12
Agilent USD 1.31B 12M 2025-01
Avanos Medical USD 598.1M 439.7M 2024-12
Becton, Dickinson and Co. USD 4.72B 74M 2024-12
Bruker USD 915.5M 119.2M 2024-12
Charles River Laboratories USD 1.17B 277.88M 2024-12
Danaher USD 5.11B 273M 2024-12
Exact Sciences USD 1.59B 841.72M 2024-12
Haemonetics USD 289.51M 4.3M 2024-12
Hologic USD 792M 34M 2024-12
Illumina USD 929M 590M 2024-12
IQVIA Holdings USD 3.33B 14M 2024-12
Merit Medical Systems USD 318.59M 16.01M 2024-12
Mettler Toledo International USD 730.58M 884.93M 2024-12
Myriad Genetics USD 249.6M 16.3M 2024-12
Neogen USD 215.56M 473.18M 2025-02
Quidel USD 808.2M 96.1M 2024-12
Revvity USD 610.62M 24.72M 2024-12
STAAR Surgical USD 76.86M 6.05M 2024-12
Thermo Fisher Scientific USD 9.38B 619M 2024-12
Waters USD 580.45M 51.28M 2024-12



Quidel Les Charges D'Exploitation - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2025.